deltatrials
Unknown NA INTERVENTIONAL 1-arm NCT04468867

Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy (RABUS)

Sponsor: The Leeds Teaching Hospitals NHS Trust

Conditions Breast Cancer
Interventions Automated whole breast ultrasound Breast MRI
Updated 5 times since 2020 Last updated: Jul 8, 2020 Started: Aug 22, 2019 Primary completion: Jun 30, 2022 Completion: Jun 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer, this trial is ongoing. The trial is conducted by The Leeds Teaching Hospitals NHS Trust and has accumulated 5 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Sep 2022 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Sep 2022 [monthly]

    Recruiting NA

  5. Aug 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Leeds Teaching Hospitals NHS Trust
Data source: The Leeds Teaching Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations